Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 235 followers
Latest posts
Last updated 1 minute ago
STAT+: HIV resurgence is feared as global fund to combat the disease falls 18%
1 minute ago
The world risks a resurgence of the HIV epidemic after international financing...
STAT+: Pharma’s drug spending deflection
about 3 hours ago
This is the online version of STAT’s weekly email newsletter Health Care...
STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
about 7 hours ago
Sarepta Therapeutics, the bruised maker of Duchenne muscular dystrophy treatments, on Monday...
STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
about 7 hours ago
Good morning, everyone, and welcome to another working week. We hope the...
Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug
about 8 hours ago
The Food and Drug Administration said Monday that Capricor Therapeutics’ stem cell...
A trend that isn’t fading, ultra-processed baby foods
about 9 hours ago
Get your daily dose of health and medicine every weekday with STAT’s...
STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease
about 9 hours ago
RA Capital and a fleet of other investors are putting $175 million...
Opinion: How midwives like me can help fight medical misinformation
about 12 hours ago
In the dimmed light of a hospital room in Nevada, the placenta...
STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities
about 12 hours ago
When students return to McGovern Medical School at UT Health Houston this...
Opinion: E-bikes, e-scooters are a burgeoning pediatric public health emergency
about 12 hours ago
When we were children, it wasn’t unusual to hear about a kid...
STAT+: Argenx to buy Forte Biosciences for $2.2B
about 13 hours ago
Argenx said Monday it would buy Forte Biosciences to expand its immunology...
Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
3 days ago
I spent nearly a decade leading FDA’s Center for Food Safety and...